Xiaohong Hou

ORCID: 0000-0002-3919-8320 · 4 papers in corpus
observational 2024
Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study
International journal of women's health ·doi:10.2147/ijwh.s454410

OBJECTIVE: Additive human menopausal gonadotropin (HMG)/recombinant luteinizing hormone (r-LH) to follicle-stimulating hormone (FSH) can improve pregnancy outcomes in patients with poor ovarian response during assisted reproductive procedur…

meta-analysis 2024
Recombinant human luteinizing hormone increases endometrial thickness in women undergoing assisted fertility treatments: a systematic review and meta-analysis
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1434625

INTRODUCTION: The optimal dosage of recombinant human luteinizing hormone (r-hLH) and its impact on endometrial thickness (EMT) when administered alongside recombinant human follicle-stimulating hormone (r-hFSH) during controlled ovarian st…

observational 2021
Clinical and perinatal outcomes of fresh single-blastocyst-transfer cycles under an early follicular phase prolonged protocol according to day of trigger estradiol levels
PeerJ ·doi:10.7717/peerj.11785

BACKGROUD: This study's objectives were to compare the clinical, perinatal, and obstetrical outcomes of patients with different estradiol (E2) levels in fresh single-blastocyst-transfer (SBT) cycles under an early follicular phase prolonged…

nonrandomized-trial 2011
Affection of Serum E2,Endometrial ER and P450arom Expression in Patients with Endometriosis after Treatment with Anastrozole

Objective To investigate the affection of serum estradiol(E2),endometrial aromatase cytochrome P450(P450arom) and estrogen receptor(ER) expression in patients with endometriosis after treatment with anastrozole.Methods Twenty cases of endom…